KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other Non-Current Liabilities (2016 - 2026)

Biogen has reported Other Non-Current Liabilities over the past 18 years, most recently at $787.1 million for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities rose 4.71% year-over-year to $787.1 million; the TTM value through Mar 2026 reached $787.1 million, up 4.71%, while the annual FY2025 figure was $748.5 million, 2.21% up from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $787.1 million at Biogen, up from $748.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.3 billion in Q1 2022 and troughed at $556.7 million in Q2 2024.
  • A 5-year average of $852.8 million and a median of $777.1 million in 2024 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 37.58% in 2023 and later soared 43.63% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $944.2 million in 2022, then decreased by 17.27% to $781.1 million in 2023, then dropped by 6.25% to $732.3 million in 2024, then rose by 2.21% to $748.5 million in 2025, then rose by 5.16% to $787.1 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for BIIB at $787.1 million in Q1 2026, $748.5 million in Q4 2025, and $761.8 million in Q3 2025.